{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:17:14Z","timestamp":1787995034349,"version":"build-2784847793"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10067-026-08284-8","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:31:56Z","timestamp":1783495916000},"page":"5863-5868","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low-dose, not low-risk: potential adrenal suppression identified by a risk-based approach to ACTH testing"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5141-5336","authenticated-orcid":false,"given":"Ryoko","family":"Asano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8668-7364","authenticated-orcid":false,"given":"Satoshi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6273-3803","authenticated-orcid":false,"given":"Koichiro","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8019-383X","authenticated-orcid":false,"given":"Hiroyuki","family":"Hounoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1111-3858","authenticated-orcid":false,"given":"Toshiki","family":"Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Kawataka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naonori","family":"Sugishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuma","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoi","family":"Kobiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2023-6585","authenticated-orcid":false,"given":"Masaru","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"8284_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/acr.21812","volume":"65","author":"J Widdifield","year":"2013","unstructured":"Widdifield J, Bernatsky S, Paterson JM et al (2013) Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis. Arthritis Care Res (Hoboken) 65:353\u2013361","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"8284_CR2","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3803\/EnM.2020.659","volume":"35","author":"JW Koh","year":"2020","unstructured":"Koh JW, Kim J, Cho H et al (2020) Effects of systemic glucocorticoid use on fracture risk: a population-based study. Endocrinol Metab (Seoul) 35:562\u2013570","journal-title":"Endocrinol Metab (Seoul)"},{"key":"8284_CR3","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/ard.2008.092163","volume":"68","author":"D Huscher","year":"2009","unstructured":"Huscher D, Thiele K, Gromnica-Ihle E et al (2009) Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 68:1119\u20131124","journal-title":"Ann Rheum Dis"},{"key":"8284_CR4","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1093\/rheumatology\/keaa011","volume":"59","author":"SW Borresen","year":"2020","unstructured":"Borresen SW, Thorgrimsen TB, Jensen B et al (2020) Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach. Rheumatology (Oxford) 59:2764\u20132773","journal-title":"Rheumatology (Oxford)"},{"key":"8284_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1510433","volume":"15","author":"Y Qiu","year":"2024","unstructured":"Qiu Y, Luo Y, Geng X, Li Y, Feng Y, Yang Y (2024) Clinical characteristics of adrenal crisis in 371 adult patients with glucocorticoid-induced adrenal insufficiency. Front Endocrinol (Lausanne) 15:1510433","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8284_CR6","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1210\/jc.2015-1218","volume":"100","author":"LH Broersen","year":"2015","unstructured":"Broersen LH, Pereira AM, Jorgensen JO, Dekkers OM (2015) Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis. J Clin Endocrinol Metab 100:2171\u20132180","journal-title":"J Clin Endocrinol Metab"},{"key":"8284_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1056\/NEJM199201233260403","volume":"326","author":"R Schlaghecke","year":"1992","unstructured":"Schlaghecke R, Kornely E, Santen RT, Ridderskamp P (1992) The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med 326:226\u2013230","journal-title":"N Engl J Med"},{"key":"8284_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1380","volume":"374","author":"A Prete","year":"2021","unstructured":"Prete A, Bancos I (2021) Glucocorticoid induced adrenal insufficiency. BMJ 374:n1380","journal-title":"BMJ"},{"key":"8284_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant 48:452\u2013458","journal-title":"Bone Marrow Transplant"},{"key":"8284_CR10","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1210\/clinem\/dgae250","volume":"109","author":"F Beuschlein","year":"2024","unstructured":"Beuschlein F, Else T, Bancos I et al (2024) European Society of Endocrinology and Endocrine Society joint clinical guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. J Clin Endocrinol Metab 109:1657\u20131683","journal-title":"J Clin Endocrinol Metab"},{"key":"8284_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5114\/reum\/170845","volume":"61","author":"E Hysa","year":"2023","unstructured":"Hysa E, Vojinovic T, Gotelli E et al (2023) The dichotomy of glucocorticosteroid treatment in immune-inflammatory rheumatic diseases: an evidence-based perspective and insights from clinical practice. Reumatologia (Warsz) 61:283\u2013293","journal-title":"Reumatologia (Warsz)"},{"issue":"Suppl 10","key":"8284_CR12","first-page":"19","volume":"25","author":"M Cutolo","year":"2002","unstructured":"Cutolo M, Foppiani L, Minuto F (2002) Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica. J Endocrinol Invest 25(Suppl 10):19\u201323","journal-title":"J Endocrinol Invest"},{"key":"8284_CR13","doi-asserted-by":"crossref","unstructured":"Sagar R, Mackie S, A WM, Stewart P, Abbas A (2021) Evaluating tertiary adrenal insufficiency in rheumatology patients on long-term systemic glucocorticoid treatment. Clin Endocrinol (Oxf) 94:361\u2013370.","DOI":"10.1111\/cen.14405"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08284-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08284-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08284-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:35:08Z","timestamp":1787992508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08284-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["8284"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08284-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Center for Clinical Research, Toyama University Hospital (approval number: R2023125).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Due to the retrospective design of the study, the requirement for written informed consent was waived. Information about the study was disclosed on the institutional website, and patients were given the opportunity to opt out.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"M Kato has received research grants from AbbVie, GlaxoSmithKline, Janssen, Nippon Shinyaku, and Novartis, as well as speaking fees from Astellas and Eli Lilly. The other authors have nothing to declare.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}